Printer Friendly

GENETICS INSTITUTE REGISTRATION STATEMENT DECLARED EFFECTIVE BY SEC FOR PROPOSED MERGER WITH AMERICAN HOME PRODUCTS CORPORATION

GENETICS INSTITUTE REGISTRATION STATEMENT DECLARED EFFECTIVE BY SEC
 FOR PROPOSED MERGER WITH AMERICAN HOME PRODUCTS CORPORATION
 CAMBRIDGE, Mass., Dec. 9 /PRNewswire/ -- Genetics Institute, Inc. (NASDAQ: GENI) announced today that the Securities and Exchange Commission has declared effective its registration statement for the depositary shares which would be issuable upon consummation of a previously-announced proposed merger between Genetics Institute and a subsidiary of American Home Products Corporation.
 A proxy statement/prospectus relating to the proposed merger, and certain other matters, is expected to be mailed to shareholders during the week of Dec. 9, 1991. A Special Meeting of Stockholders has been scheduled for Jan. 16, 1992 to consider and vote upon, among other things, the proposed merger.
 Genetics Institute is a leading biopharmaceutical firm engaged in the discovery and development of human pharmaceuticals through recombinant DNA and other technologies. The company has a diversified portfolio of licensed and proprietary pharmaceutical products.
 -0- 12/9/91
 /CONTACT: Melinda Lindquist or Clare Clifford, both of Genetics Institute, 617-876-1170/
 (GENI) CO: Genetics Institute ST: Massachusetts IN: MTC SU:


KM -- NE011 -- 0537 12/09/91 12:08 EST
COPYRIGHT 1991 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Dec 9, 1991
Words:183
Previous Article:GENERON SYSTEMS INTRODUCES NEW MEMBRANE MODULE
Next Article:KCS GROUP EARNINGS UP FOR 1991 FISCAL YEAR
Topics:


Related Articles
GENETICS INSTITUTE SETS RECORD DATE FOR SPECIAL MEETING
GENETICS INSTITUTE SHAREHOLDERS VOTE TO APPROVE MERGER WITH AMERICAN HOME PRODUCTS
GENETICS INSTITUTE, INC. TO REDEEM CONVERTIBLE EXCHANGEABLE PREFERRED STOCK
GENETICS INSTITUTE REPORTS 1993 FINANCIAL RESULTS
TARGETED GENETICS ANNOUNCES FINANCING PLANS
TARGETED GENETICS FILES REGISTRATION STATEMENT FOR PUBLIC OFFERING OF 3,500,000 SHARES OF COMMON STOCK
American Home Products Biotech Subsidiary, Genetics Institute, Receives FDA License for Novel Hemophilia B Therapy
deCODE genetics and MediChem Life Sciences Receive Early Hart-Scott-Rodino Clearance.
GenStar Therapeutics Announces Operational Changes to Reduce Expenses And Concentrate Resources on Later Stage Lead Cardiovascular Products of...
Targeted Genetics Announces Effectiveness of Its Shelf Registration Statement.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters